Online Drug Supplier 111 Finds Tonic in B2B Focus
Company adds two fulfillment centers, inks deal with cancer drug maker BeiGene, in drive to consolidate its place as premier B2B specialist Key takeaways 111 Inc.’s aggressive pursuit of partnerships…
Recent Articles
RELATED ARTICLES
- Margins ring alarm bells as 160 Health readies IPO
-
Ping An Health pins recovery hopes on new leadership
1833.HK
-
Profits recover at Alibaba Health but prognosis unclear
0241.HK
-
Slowing revenue growth hurts online drug platform YSB
9885.HK
-
IFlytek hives off health unit to fund AI medical drive
002230.SHE
- Medical imaging group Rimag sets growth focus with IPO
-
Akeso marks profit milestone with swift rights issue
9926.HK
Discover hidden China stock gems in our weekly newsletter